APW
ASND icon

Aventura Private Wealth’s Ascendis Pharma A/S ASND Stock Holding History

Aventura Private Wealth’s Portfolio ASND Stock Details ASND Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-69
Closed -$15.8K – 986
2026
Q1 		$15.8K Sell
69
-5
-7% -$1.12K 0.01% 477
2025
Q4 		$15.8K Buy
74
+17
+30% +$3.51K 0.01% 453
2025
Q3 		$11.3K Hold
57
– – ﹤0.01% 478
2025
Q2 		$9.84K Hold
57
– – ﹤0.01% 466
2025
Q1 		$8.88K Hold
57
– – ﹤0.01% 457
2024
Q4 		$7.85K Buy
+57
New +$7.49K ﹤0.01% 461

Other funds holding ASND

RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return
Westfield Capital Management
Westfield Capital Management Boston, Massachusetts $30.6B AUM 61.81% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $63.1B AUM 35.51% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return

Aventura Private Wealth's ASND Position: Q2 2026 in Review

Aventura Private Wealth sold out of Ascendis Pharma A/S (ASND) in Q2 2026, closing a stake of 69 shares — an estimated $15.8K sold.

Aventura Private Wealth first reported a position in ASND in Q4 2024 and held it in 6 quarters. The position peaked at $15.8K in Q1 2026. 313 funds tracked by Wall St. Rank hold ASND as of Q2 2026.

  • Aventura Private Wealth reported no remaining Ascendis Pharma A/S position as of Q2 2026 after selling out during the quarter.
  • Aventura Private Wealth sold 69 Ascendis Pharma A/S shares in Q2 2026, an estimated $15.8K.
  • Aventura Private Wealth first reported a position in Ascendis Pharma A/S in Q4 2024 and held it in 6 quarters.
  • Aventura Private Wealth's Ascendis Pharma A/S position peaked at $15.8K in Q1 2026.
  • 313 funds tracked by Wall St. Rank held Ascendis Pharma A/S as of Q2 2026.

Based on Aventura Private Wealth's 13F filing for Q2 2026, filed 15 Jul 2026.